Clinical Faculty Bio
Jessica T. Delaney, M.D. 
Assistant Professor                                                                
Division of Cardiovascular MedicineJessica Delaney, MD

 
Academic offices:
Department of Internal Medicine
982265 Nebraska Medical Center
Omaha, NE 68198-2265
 
Practice Locations:
Omaha, Nebraska
Durham Outpatient Center
For An Appointment Call (402)559-8888
Toll Free 1-800-97-HEART (1-800-974-3278)

Oakview Medical Building
For An Appointment Call (402)559-8888
Toll Free 1-800-97-HEART (1-800-974-3278)
 
Hospital Appointments:
Nebraska Medicine
 
Board Certification:
Cardiovascular Medicine
Nuclear Cardiology
Clinical Cardiac Electrophysiology
 
Education:
Albert Einstein College of Medicine (Bronx, NY)
Doctor of Medicine, 2003
Resident – Internal Medicine, 2006
St. Luke’s – Roosevelt Medical Center (New York, NY)
Fellow – Cardiovascular Medicine, 2009
Vanderbilt University Medical Center (Nashville, TN)
Fellow – Clinical Pharmacy, 2012
Fellow – Clinical Cardiac Electrophysiology, 2014
 
Clinical Interests:
Management of complex arrhythmia cases
Genetic arrhythmia syndromes
 
Research Interests:
Understanding the interplay of common and rare mutations on genetic arrhythmia syndrome and common arrhythmia diseases including atrial fibrillation.
 
Selected Publications:
  1. Weeke P, Muhammad R, Delaney JT,et al; National Heart, Lung, and Blood Institute (NHLBI) GO Exome Sequencing Project.  Whole-exome sequencing in familial atrial fibrillation.  Eur Heart J. 2014 Sep 21;35(36):2477-83.
  2. Delaney JT, Muhammad R, Shi Y, et al.  Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation.  Europace. 2014 Apr;16(4):485-90.
  3. Weeke P, Mosley JD, Hanna D, Delaney JT, et al.  Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome.  J Am Coll Cardiol. 2014 Apr 15;63(14):1430-7.
  4. Delaney JT, Muhammad R, Shi Y, et al.  Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation.  Europace. 2014 Apr;16(4):485-90.
  5. Weeke P, Delaney J, Mosley JD, et al.  QT variability during initial exposure to sotalol: experience based on a large electronic medical record.  Europace. 2013 Dec;15(12):1791-7.
  6. Delaney JT, Muhammad R, Blair MA, et al.  A KCNJ8 mutation associated with early repolarization and atrial fibrillation.  Europace. 2012 Oct;14(10):1428-32.
  7. Delaney JT, Jeff JM, Brown NJ, et al.  Characterization of genome-wide association-identified variants for atrial fibrillation in African Americans.  PLoS One. 2012;7(2):e32338.
  8. Wells QS, Delaney JT, Roden DM.  Genetic determinants of response to cardiovascular drugs. Curr Opin Cardiol. 2012 May;27(3):253-61.
  9. Ramirez AH, Shi Y, Schildcrout JS, Delaney JT, et al.  Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record. Pharmacogenomics. 2012 Mar;13(4):407-18.
  10. Kamath GS, Zareba W, Delaney J, et al.  Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia.  Heart Rhythm. 2011 Feb;8(2):256-62.

     For more publications